Knowledge

Mutated citrullinated vimentin

Source 📝

108: 59:. Detection of specific autoantibodies (antibodies directed against the body’s own tissue) such as rheumatoid factors and ACPAs may provide indication of the disease. In many cases, autoimmune diagnostics are crucial for diagnosing RA correctly and already in the disease’s early stages, when typical symptoms often are lacking but when medical therapy is most effective. 133:
for estimating progress of rheumatoid arthritis. Main advantage of testing for anti-MCV is the early appearance of the anti-MCV antibodies, what allows for detection of early RA and submits adequate therapy just after the disease’s onset. Moreover, anti-MCV titres show strong correlation to disease
307:
Bang, Holger; Egerer, Karl; Gauliard, Anke; Lüthke, Kirsten; Rudolph, Paul E.; Fredenhagen, Gert; Berg, Wigbert; Feist, Eugen; Burmester, Gerd-R. (2007). "Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis".
398:"Antibodies against citrullinated vimentin in rheumatoid arthritis: Higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides" 126:(POCT) for the early detection of RA has been developed. This assay combines the detection of rheumatoid factor and anti-MCV for diagnosis of rheumatoid arthritis and shows a sensitivity of 72% and specificity of 99.7%. 118:
In rheumatology diagnostics, autoantibodies against mutated citrullinated vimentin (anti-MCV) are of prominent diagnostic and prognostic value. Their significance is greater than that of rheumatoid factor.
270:"Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review" 92:
Various kinds of citrullinated proteins have been detected in the joints of RA patients. One of these is Sa antigen, now known as mutated citrullinated vimentin (MCV).
343:
Roland, Pascale; Mignot, Sabine; Bruns, Alessandra; Hurtado, Margarita; Palazzo, Elisabeth; Hayem, Gilles; Dieudé, Philippe; Meyer, Olivier; Martin, Sylvie (2008).
151:
György, Bence; Tóth, Erzsébet; Tarcsa, Edit; Falus, András; Buzás, Edit I. (2006). "Citrullination: A posttranslational modification in health and disease".
345:"Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy" 186:
Després, N; Boire, G; Lopez-Longo, FJ; Ménard, HA (1994). "The Sa system: A novel antigen-antibody system specific for rheumatoid arthritis".
396:
Mathsson, Linda; Mullazehi, Mohammed; Wick, Marius C.; Sjöberg, Olof; Van Vollenhoven, Ronald; Klareskog, Lars; Rönnelid, Johan (2008).
33: 239: 213: 349: 89:. The modified (citrullinated) protein may be identified by as foreign, provoking an autoimmune inflammation response. 111: 25: 56: 443: 419: 378: 325: 289: 195: 168: 29: 409: 368: 358: 317: 281: 247: 160: 240:"Anti-MCV Antibody Test for the Diagnosis of Rheumatoid Arthritis Using a POCT-Immunoassay" 269: 238:
Renger F, Bang H, Fredenhagen G, Natusch A, Backhaus M, Feist E, Egerer K, Burmester GR.
373: 344: 67: 17: 437: 244:
American College of Rheumatology, 2008 Annual Scientific Meeting, Poster Presentation
217: 164: 107: 86: 75: 285: 130: 423: 382: 329: 293: 172: 199: 96: 78: 71: 414: 397: 321: 82: 363: 106: 123: 153:
The International Journal of Biochemistry & Cell Biology
32:(RF negative sera). Anti-MCV antibodies are a member of the 268:
Luime, J J; Colin, E M; Hazes, J M W; Lubberts, E (2009).
114:
for rheumatoid arthritis using the rheumachec rapid test
134:
activity, disease severity and the success of therapy.
28:(RA) diagnostics, especially in sera negative for 8: 216:. Exagen Diagnostics. 2010. Archived from 99:plays a decisive role in RA pathogenesis. 413: 372: 362: 143: 70:is a modification of proteins where a 7: 14: 36:family, a group of the so-called 350:Arthritis Research & Therapy 274:Annals of the Rheumatic Diseases 129:Anti-MCV are used as efficient 22:mutated citrullinated vimentin 1: 165:10.1016/j.biocel.2006.03.008 188:The Journal of Rheumatology 55:Rheumatoid arthritis is an 460: 402:Arthritis & Rheumatism 310:Arthritis & Rheumatism 286:10.1136/ard.2008.103283 122:Recently a serological 115: 112:point-of-care testing 110: 85:, converting it into 81:is replaced with an 26:rheumatoid arthritis 57:autoimmune disorder 124:point-of-care test 116: 95:Citrullination of 415:10.1002/art.23188 322:10.1002/art.22817 30:rheumatoid factor 451: 428: 427: 417: 393: 387: 386: 376: 366: 340: 334: 333: 304: 298: 297: 265: 259: 258: 256: 255: 246:. Archived from 235: 229: 228: 226: 225: 210: 204: 203: 183: 177: 176: 148: 459: 458: 454: 453: 452: 450: 449: 448: 434: 433: 432: 431: 395: 394: 390: 342: 341: 337: 306: 305: 301: 267: 266: 262: 253: 251: 237: 236: 232: 223: 221: 212: 211: 207: 185: 184: 180: 159:(10): 1662–77. 150: 149: 145: 140: 105: 65: 48:rotein/peptide 12: 11: 5: 457: 455: 447: 446: 436: 435: 430: 429: 388: 364:10.1186/ar2570 335: 316:(8): 2503–11. 299: 260: 230: 205: 194:(6): 1027–33. 178: 142: 141: 139: 136: 104: 101: 68:Citrullination 64: 61: 18:autoantibodies 13: 10: 9: 6: 4: 3: 2: 456: 445: 442: 441: 439: 425: 421: 416: 411: 407: 403: 399: 392: 389: 384: 380: 375: 370: 365: 360: 356: 352: 351: 346: 339: 336: 331: 327: 323: 319: 315: 311: 303: 300: 295: 291: 287: 283: 280:(2): 337–44. 279: 275: 271: 264: 261: 250:on 2012-02-27 249: 245: 241: 234: 231: 220:on 2013-03-23 219: 215: 209: 206: 201: 197: 193: 189: 182: 179: 174: 170: 166: 162: 158: 154: 147: 144: 137: 135: 132: 127: 125: 120: 113: 109: 102: 100: 98: 93: 90: 88: 84: 80: 77: 73: 69: 62: 60: 58: 53: 51: 47: 44:itrullinated 43: 40:ntibodies to 39: 35: 31: 27: 23: 19: 16:Detection of 408:(1): 36–45. 405: 401: 391: 354: 348: 338: 313: 309: 302: 277: 273: 263: 252:. Retrieved 248:the original 243: 233: 222:. Retrieved 218:the original 208: 191: 187: 181: 156: 152: 146: 128: 121: 117: 103:Significance 94: 91: 66: 54: 49: 45: 41: 37: 21: 15: 357:(6): R142. 214:"Avise MCV" 24:is part of 254:2012-11-20 224:2012-11-20 138:References 131:biomarkers 87:citrulline 76:amino acid 444:Arthritis 52:ntigens. 438:Category 424:18163519 383:19077182 330:17665451 294:19289382 173:16730216 97:vimentin 79:arginine 72:nitrogen 20:against 374:2656247 200:7932409 74:in the 422:  381:  371:  328:  292:  198:  171:  83:oxygen 63:Basics 420:PMID 379:PMID 326:PMID 290:PMID 196:PMID 169:PMID 34:ACPA 410:doi 369:PMC 359:doi 318:doi 282:doi 161:doi 440:: 418:. 406:58 404:. 400:. 377:. 367:. 355:10 353:. 347:. 324:. 314:56 312:. 288:. 278:69 276:. 272:. 242:. 192:21 190:. 167:. 157:38 155:. 426:. 412:: 385:. 361:: 332:. 320:: 296:. 284:: 257:. 227:. 202:. 175:. 163:: 50:a 46:p 42:c 38:a

Index

autoantibodies
rheumatoid arthritis
rheumatoid factor
ACPA
autoimmune disorder
Citrullination
nitrogen
amino acid
arginine
oxygen
citrulline
vimentin

point-of-care testing
point-of-care test
biomarkers
doi
10.1016/j.biocel.2006.03.008
PMID
16730216
PMID
7932409
"Avise MCV"
the original
"Anti-MCV Antibody Test for the Diagnosis of Rheumatoid Arthritis Using a POCT-Immunoassay"
the original
"Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review"
doi
10.1136/ard.2008.103283
PMID

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.